FDA NDC Directory · JSON-LD · Markdown

Guaifenesin and Pseudoephedrine Hydrochloride

NDC 0363-0077 · HUMAN OTC DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerWALGREEN COMPANY
Marketing categoryNew Drug Application (innovator) · App NDA021585
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsGUAIFENESIN (600 mg/1)
PSEUDOEPHEDRINE HYDROCHLORIDE (60 mg/1)
Marketing started20170801
Package count2

External sources

Source: openFDA. Public-domain (CC0).